Mark Murray
2014 - Arbutus Biopharma Corp
In 2014, Mark Murray earned a total compensation of $1.1M as President and Chief Executive Officer at Arbutus Biopharma Corp, a 87% increase compared to previous year.
Compensation breakdown
| Bonus | $180,000 |
|---|---|
| Option Awards | $466,404 |
| Salary | $400,000 |
| Other | $38,848 |
| Total | $1,085,252 |
Murray received $466.4K in option awards, accounting for 43% of the total pay in 2014.
Murray also received $180K in bonus, $400K in salary and $38.8K in other compensation.
Rankings
In 2014, Mark Murray's compensation ranked 7,239th out of 13,032 executives tracked by ExecPay. In other words, Murray earned more than 44.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,239 out of 13,032 | 45th |
Division Manufacturing | 2,666 out of 4,965 | 46th |
Major group Chemicals And Allied Products | 905 out of 1,690 | 46th |
Industry group Drugs | 712 out of 1,369 | 48th |
Industry Pharmaceutical Preparations | 547 out of 1,042 | 48th |
Source: SEC filing on April 18, 2017.
Murray's colleagues
We found three more compensation records of executives who worked with Mark Murray at Arbutus Biopharma Corp in 2014.
News
Jones Soda CEO David Knight receives $1.4M in 2023
April 3, 2024
Jones Soda CEO Mark Murray's 2022 pay rises 5% to $406K
April 5, 2023
Jones Soda CEO Mark Murray's 2021 pay jumps 58% to $386K
April 1, 2022
Jones Soda CEO Mark Murray's 2020 pay falls 94% to $243K
April 1, 2021
Arbutus Biopharma Corp CEO Mark Murray's 2019 pay jumps 50% to $3.8M
April 24, 2020
Arbutus Biopharma Corp CEO Mark Murray's 2018 pay jumps 32% to $2.5M
April 23, 2019